Fresenius Kabi AG
Fresenius Kabi is operating in the business area of infusion and nutrition therapy
Fresenius Kabi AG is a subsidiary of Fresenius AG and has approximately 11,000 employees in more than 30 countries. Fresenius Kabi was established in 1999 by combining the Pharma division of the Fresenius Group with the infusion solution business acquired from Pharmacia & Upjohn (Kabi).
Rainer Baule, CEO
Christian Fischer, CFO
Klaus Mokros
Marc Crouton
John Ducker
Mats Henriksson
Michael Schönhofen, Dr.
Else-Kröner-Strasse 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49-6172-686-0
Fax: +49-6172-686-2628
The company develops and markets intravenous solutions, active ingredients and medical-technical products. This includes products for fluid and blood volume replacement and anaesthetic agents for general anaesthesia. Fresenius Kabi AG also provides parenteral and enteral nutrition as well as a total system concept for processing extracorporeal blood. The company is particularly active in the field of parenteral medication, parenteral and enteral nutrition, tracheostomy care, wound management and incontinence care.
The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.
Related patents
- Production o Bioactive Glycoproteins from Inactive Starting Materials by Conjugation with Hydroxyalkylstarch
- Starch Derivatives, Starch Active Substance Conjugates, Method for the Production Thereof and Their Use as Medicaments
- Device for Feeding Sachets onto a Linear Transport
- Paediatric Amino Acid Solution for Parenteral Nutrition
- Closing Cap for Containers Filled with Medical Liquids
- Flexible Multi-chamber Container for the Preparation of Medical Mixed Solutions
- Medical Container with Improved Peelable Seal
- Vorrichtung zum Aufhängen eines Behälters, Insbesondere eines Beutels zur Aufnahme einer Flüssigkeit für die Flüssigkeitsbilanzierung bei einer Enteralen Ernährung und Behälter, Insbesondere Beutel mit einer Derartigen Aufhängevorrichtung
- Improved Containers for Parenteral Fluids
- Adapter for a Percutaneous Endoscopic Gastrostomy (PEG) Probe
- Conjugados de Hidroxialquil Amido e Uma Proteìna
- Formulation, Which Can Be Administered Gastrointestinally, Containing Green Tea Extract and an No Donor
- Adapter for a Peg Probe
- Device for Continuously Delivering Bags
- Conjugates of Hydroxyalkyl Starch and a Protein, Prepared by Reductive Amination
- Sterile Port
- Conjugates of Hydroxyalkyl Starch and a Protein
- Hasylated Polypeptides Especially Hasylated Erythropoietin
- Conjugates of Hydroxyalkyl Starch and a Protein, Prepared by Reductive Amination
- Flexible Multi-chamber Container for the Preparation of Medical Mixed Solutions
- Formulation, which Can Be Administered Gastrointestinally, Containing Green Tea Extract and an No Donor
- Connector for Packings Containing Medical Liquids, and Corresponding Packing for Medical Liquids
- Medical Container with Improved Peelable Seal
- Medical Packaging Unit
- Conjugates of Hydroxyalkyl Starch and a Protein
- Connector for Medical Liquid-containing Packages and Medical Liquid-containing Packages
- Conjugates of Hydroxyalkyl Starch and an Active Substance, Prepared by Chemical Ligation via Thiazolidine
- Probe with Gastric and Intestinal Sections Comprises a Lumen Extending to the Distal End of the Gastric Section, and Two Lumina Extending to the Distal End of the Intestinal Section
- Hydroxyalkyl Starch Derivatives
- Conjugated Hydroxyalkyl Starch Allergen Compounds
- Medical Containers
- Feed Tube System Used in Enteral Feeding for Jejunal Supply of Feeding Substrates Comprises a Jejunal Feed Tube, a Multichanneled Endoscope Tube
- Device for Regulating the Flow through Tubes and Enteral Delivery System Comprising such a Device
- Pharmaceutical Preperation Comprising a Growth Factor and/or a Cytokine and an Antiseptic Biguanide
- Hydroxyalkylstärke-Derivate
- Withdrawal and Injection System for Medical Solutions and a Container with Said Withdrawal and Injection System
- Apparatus for Determining at Least One Value Specific to Nutrition
- Improved Containers for Parental Fluids
- HASylated Polypeptides, Especially HASylated Erythropoietin
- Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung
- Supplement to Be Enterally Administered for Parenteral Nutrition or Partial Enteral/Oral Nutrition of the Critically Ill, the Chronically Ill and People with Malnutrition